Nivolumab versus chemotherapy in patients with advanced melanoma who p rogressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, c ontrolled, open-label, phase 3 trial
Monitoring dosage is crucial to prevent adverse effects and maximize benefits
Looking deeper into the data, 60% of participants on CagriSema achieved at least 20% weight loss
Several researchers have proposed intranasal delivery to reduce first-pass degradation and allow direct olfactory-pathway CNS access
Using clean injection sites, rotating locations, and following appropriate reconstitution procedures minimizes infection risk and local tissue reactions
The scientists concluded that The present study proposed that AHK-Cu promotes the growth of hair follicles, and this stimulatory effect may occur due to stimulation of the proliferation and the preclusion of the apoptosis of DPCs. The hormone dihydrosterone is considered to be a primary contributor to progressive loss